BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7106167)

  • 1. Pharmacokinetics of furosemide in patients with hepatic cirrhosis.
    González G; Arancibia A; Rivas MI; Caro P; Antezana C
    Eur J Clin Pharmacol; 1982; 22(4):315-20. PubMed ID: 7106167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furosemide kinetics in patients with hepatic cirrhosis with ascites.
    Fuller R; Hoppel C; Ingalls ST
    Clin Pharmacol Ther; 1981 Oct; 30(4):461-7. PubMed ID: 7285480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide.
    Keller E; Hoppe-Seyler G; Mumm R; Schollmeyer P
    Eur J Clin Pharmacol; 1981; 20(1):27-33. PubMed ID: 7308269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furosemide kinetics and dynamics in patients with cirrhosis.
    Villeneuve JP; Verbeeck RK; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1986 Jul; 40(1):14-20. PubMed ID: 3720175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furosemide disposition in cirrhosis.
    Verbeeck RK; Patwardhan RV; Villeneuve JP; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1982 Jun; 31(6):719-25. PubMed ID: 7075120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis.
    Traeger A; Häntze R; Penzlin M; Krombholz B; Reinhardt M; Keil E; Jorke D
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):129-33. PubMed ID: 3997298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver.
    Brunner G; von Bergmann K; Häcker W; von Möllendorff E
    Arzneimittelforschung; 1988 Jan; 38(1A):176-9. PubMed ID: 3285830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of cimetidine on furosemide kinetics and dynamics in patients with hepatic cirrhosis.
    Sanchis Closa A; Lambert C; du Souich P
    Int J Clin Pharmacol Ther Toxicol; 1993 Sep; 31(9):461-6. PubMed ID: 8225696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites].
    Brunkhorst R; Wrenger E; Kühn K; Schmidt FW; Koch K
    Klin Wochenschr; 1989 Aug; 67(15):774-83. PubMed ID: 2671477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Furosemide disposition in cirrhotic patients.
    Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
    Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients.
    Chalasani N; Gorski JC; Horlander JC; Craven R; Hoen H; Maya J; Brater DC
    J Am Soc Nephrol; 2001 May; 12(5):1010-1016. PubMed ID: 11316860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torasemide versus furosemide in cirrhosis: a long-term, double-blind, randomized clinical study.
    Fiaccadori F; Pedretti G; Pasetti G; Pizzaferri P; Elia G
    Clin Investig; 1993 Jul; 71(7):579-84. PubMed ID: 8374255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics and diuretic effect of furosemide in plain tablet and retard capsule with normal subjects and cirrhotic patients.
    Uchino K; Isozaki S; Amano J; Tanaka N; Saitoh Y; Nakagawa F; Tamura Z; Oka H
    J Pharmacobiodyn; 1983 Sep; 6(9):684-91. PubMed ID: 6655548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of furosemide on diuresis and salt diuresis, blood electrolytes concentrations in various aspects of renal function in liver cirrhotic patients with ascites].
    Bardi A; Merino I; Doerr E; Rendic Y; Generini G; Plaza de los Reyes M
    Rev Med Chil; 1968 Mar; 96(3):142-4. PubMed ID: 5732745
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical program of therapy for ascitic edema in liver disease].
    Pupita F; Ansuini R; Frausini G
    Clin Ter; 1982 Jan; 100(2):115-33. PubMed ID: 7186421
    [No Abstract]   [Full Text] [Related]  

  • 16. Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers.
    van Meyel JJ; Smits P; Russel FG; Gerlag PG; Tan Y; Gribnau FW
    Clin Pharmacol Ther; 1992 Apr; 51(4):440-4. PubMed ID: 1563213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulindac and indomethacin suppress the diuretic action of furosemide in patients with cirrhosis and ascites: evidence that sulindac affects renal prostaglandins.
    Daskalopoulos G; Kronborg I; Katkov W; Gonzalez M; Laffi G; Zipser RD
    Am J Kidney Dis; 1985 Oct; 6(4):217-21. PubMed ID: 3901735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ampicillin in cirrhosis.
    Lewis GP; Jusko WJ
    Clin Pharmacol Ther; 1975 Oct; 18(4):475-84. PubMed ID: 1164828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Dose Oral Furosemide with Salt Ingestion in the Treatment of Refractory Ascites of Liver Cirrhosis.
    Yakar T; Demir M; Dogan O; Parlakgumus A; Ozer B; Serin E
    Clin Invest Med; 2016 Dec; 39(6):27502. PubMed ID: 27917793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.